Related Experiment Video
Updated: Aug 20, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: A multicenter
Stefan Kaspers1, Olga Kordonouri, Edith Schober
1University Children's Hospital, Essen, Germany. S.Kaspers@gmx.de
Insights
Children with type 1 diabetes (T1D) and celiac disease (CD) experienced earlier diabetes onset and reduced growth. This highlights the importance of screening for CD in T1D patients.
Area of Science:
- Pediatric Endocrinology
- Autoimmune Diseases
- Gastroenterology
Background:
- Type 1 diabetes (T1D) and celiac disease (CD) are autoimmune conditions that can co-occur in children.
- The impact of CD on growth and metabolic control in pediatric T1D patients is not fully understood.
- Early identification and management of co-existing conditions are crucial for optimal patient outcomes.
Purpose of the Study:
- To investigate the influence of celiac disease (CD) on growth and metabolic control in a nationwide cohort of children and adolescents with type 1 diabetes (T1D).
Main Methods:
- Analysis of data from 19,796 pediatric patients with T1D from the German DPV-database.
- Assessment of CD occurrence through serological markers and small-bowel biopsy confirmation.
- Comparison of growth parameters (height-SDS, BMI-SDS) and metabolic control (HbA1c) between T1D patients with and without CD.
Main Results:
- Celiac disease antibodies were found in 6.7% of T1D patients, with biopsy-confirmed CD in 0.6%.
- T1D patients with CD were diagnosed at a younger age and exhibited significantly lower height-SDS at onset and during follow-up.
- Female subjects showed a higher predisposition for both T1D and CD. Thyroid disease was more prevalent in the T1D with CD group.
Conclusions:
- Celiac disease is associated with earlier diabetes onset and impaired growth in pediatric patients with type 1 diabetes.
- These findings underscore the clinical significance of screening for celiac disease in children and adolescents diagnosed with autoimmune diabetes.
- Integrated management strategies are essential for addressing the complexities of co-existing T1D and CD.
Objective:
To investigate the influence of celiac disease (CD) on growth and metabolic control in a nationwide cohort of children and adolescents with type 1 diabetes (T1D).
Study Design:
We analyzed data from 19,796 pediatric patients with T1D in the German pediatric multicenter DPV-database for occurrence of CD.
Results:
CD-specific antibodies were present in 1326 patients (6.7%). The diagnosis was confirmed in 127 patients (0.6%) by small-bowel biopsy. Female subjects were significantly more predisposed to have T1D and CD. The CD-affected patients in our cohort were significantly younger at diabetes onset. Furthermore, they had significantly lower height-SDS at onset (-0.49 vs -0.06, P < .05), a difference that increased during the course of the disease (-0.80 vs -0.26 after 9 years of diabetes, P < .05). In addition, body mass index-SDS significantly differed between the groups (0.22 vs 0.47, P < .05). Evidence for thyroid disease was more commonly observed in the T1D with CD group (6.3% vs 2.3%, P < .05). HbA1c values were lower in the patients with T1D and CD.
Conclusions:
The CD-positive patients were characterized by earlier onset of diabetes and decreased growth and weight gain. These findings emphasize the clinical relevance of celiac disease in patients with autoimmune diabetes.
Related Concept Videos
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational

